Reported 227,807 shares, down 561,504 (71.1%) from the prior quarter.
Reported value -80.8%; share count -71.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 55090000 |
| 2021-12-31 | 72516000 |
| 2022-03-31 | 56183000 |
| 2022-06-30 | 10768000 |
| 2022-09-30 | 12641000 |
| 2022-12-31 | 11337761 |
| 2023-03-31 | 10650885 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -263,375 (-100.0%) | 0 | $0 | 2023-08-14 | |
| Q1 2023 | Added | 263,375 | +19,657 (8.1%) | 0.04% | $10,650,885 | 2023-05-15 | |
| Q4 2022 | Unchanged | 243,718 | 0 (0.0%) | 0.04% | $11,337,761 | 2023-02-14 | |
| Q3 2022 | Added | 243,718 | +15,911 (7.0%) | 0.05% | $12,641,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 227,807 | -561,504 (-71.1%) | 0.04% | $10,768,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 789,311 | -180,425 (-18.6%) | 0.18% | $56,183,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 969,736 | 0 (0.0%) | 0.24% | $72,516,000 | 2022-02-14 | |
| Q3 2021 | Added | 969,736 | +936,536 (2820.9%) | 0.2% | $55,090,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
175 managers reported ENANTA PHARMACEUTICALS INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 3,518,736 | +2,130 | < 0.01% | $166,331,000 | 33 qtrs |
| ARMISTICE CAPITAL LLC | Added | 2,070,000 | +946,000 | 1.71% | $97,849,000 | 25 qtrs |
| STATE STREET CORPORATION | Added | 1,699,428 | +390,842 | < 0.01% | $80,332,000 | 36 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 1,550,000 | 0 | 0.4% | $73,269,000 | 20 qtrs |
| VANGUARD GROUP INC | Reduced | 1,516,689 | -72,535 | < 0.01% | $71,694,000 | 37 qtrs |
| NORTHERN TRUST CORPORATION | Added | 931,291 | +3,198 | < 0.01% | $44,022,000 | 37 qtrs |
| RA CAPITAL MANAGEMENT L P | Reduced | 896,724 | -67,488 | 1.13% | $42,389,000 | 2 qtrs |
| Krensavage Asset Management LLC | Added | 624,768 | +75,940 | 9.76% | $29,533,000 | 30 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 542,800 | -64,300 | 0.03% | $25,658,000 | 26 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 523,709 | -69,811 | < 0.01% | $24,756,000 | 30 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 15, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 218,407
- Shared
- 9,400
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.